These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11861372)
1. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Li Z; Moore DH; Meng ZH; Ljung BM; Gray JW; Dairkee SH Cancer Res; 2002 Feb; 62(4):1000-3. PubMed ID: 11861372 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite analysis of breast carcinoma and corresponding local recurrences. Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878 [TBL] [Abstract][Full Text] [Related]
3. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer. Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336 [TBL] [Abstract][Full Text] [Related]
4. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. Li Z; Meng ZH; Chandrasekaran R; Kuo WL; Collins CC; Gray JW; Dairkee SH Cancer Res; 2002 Apr; 62(7):1939-43. PubMed ID: 11929806 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281 [TBL] [Abstract][Full Text] [Related]
6. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743 [TBL] [Abstract][Full Text] [Related]
7. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881 [TBL] [Abstract][Full Text] [Related]
8. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400 [TBL] [Abstract][Full Text] [Related]
9. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM Breast J; 2006; 12(4):331-7. PubMed ID: 16848842 [TBL] [Abstract][Full Text] [Related]
10. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. Larson PS; Schlechter BL; de las Morenas A; Garber JE; Cupples LA; Rosenberg CL J Clin Oncol; 2005 Dec; 23(34):8613-9. PubMed ID: 16314623 [TBL] [Abstract][Full Text] [Related]
11. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal component. Gaki V; Tsopanomichalou M; Sourvinos G; Tsiftsis D; Spandidos DA Eur J Surg Oncol; 2000 Aug; 26(5):455-60. PubMed ID: 11016465 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. Lakhani SR; Chaggar R; Davies S; Jones C; Collins N; Odel C; Stratton MR; O'Hare MJ J Pathol; 1999 Dec; 189(4):496-503. PubMed ID: 10629549 [TBL] [Abstract][Full Text] [Related]
13. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803 [TBL] [Abstract][Full Text] [Related]
14. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548 [TBL] [Abstract][Full Text] [Related]
15. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Jolly S; Kestin LL; Goldstein NS; Vicini FA Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression. Li Z; Meng ZH; Sayeed A; Shalaby R; Ljung BM; Dairkee SH Cancer Res; 2002 Oct; 62(20):5980-7. PubMed ID: 12384566 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974 [TBL] [Abstract][Full Text] [Related]
18. Location of several putative genes possibly involved in human breast cancer progression. Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747 [TBL] [Abstract][Full Text] [Related]
19. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]